| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |